Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Liposomal daunorubicin 50mg/25mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Daunorubicin liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Daunorubicin citrate liposomal 2mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Daunorubicin liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing daunorubicin liposome |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Daunorubicin liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Daunorubicin citrate liposome (substance) |
Is a |
False |
Daunorubicin liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Daunorubicin citrate liposome (substance) |
Is modification of (attribute) |
True |
Daunorubicin liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing only daunorubicin liposome (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Daunorubicin liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only daunorubicin liposome in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Daunorubicin liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Daunorubicin hydrochloride liposome (substance) |
Is modification of (attribute) |
True |
Daunorubicin liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely cytarabine liposome 100 milligram and daunorubicin liposome 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has precise active ingredient |
True |
Daunorubicin liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely cytarabine liposome 100 milligram and daunorubicin liposome 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Daunorubicin liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only cytarabine liposome and daunorubicin liposome (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Daunorubicin liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Cytarabine liposome and daunorubicin liposome only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Daunorubicin liposome (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |